Search
Find a recruiting study
7,120 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 26, 2026). No sign-up needed.
Most recently updated studies · page 51 of 297
- RecruitingPhase 2
A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVO
EyeBiotech Ltd.
- Location
- Scottsdale, AZ + 54 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated…
Pulnovo Medical, Inc.
- Location
- Tucson, AZ + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 1/Phase 2
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Sanofi
- Location
- Peoria, AZ + 30 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 2
Transition to KPL-387 Monotherapy Dosing & Administration Study
Kiniksa Pharmaceuticals International, plc
- Location
- Phoenix, AZ + 20 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Deep Sleep in Older Adults
Proactive Life Inc
- Location
- New York, NY
- Eligibility basics
- Ages 55+
- Recruiting
Delivering tAN to Reduce HMB: The LUNA Study
Spark Biomedical, Inc.
- Location
- Boston, MA
- Eligibility basics
- Ages 14–45 · Women only
- RecruitingPhase 3
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Medipost, Inc.
- Location
- Birmingham, AL + 33 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Generate Biomedicines
- Location
- Bakersfield, CA + 21 other US sites
- Eligibility basics
- Ages 12–80
- Recruiting
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
MedtronicNeuro
- Location
- Homewood, AL + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
Alnylam Pharmaceuticals
- Location
- Chula Vista, CA
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Biomea Fusion Inc.
- Location
- Birmingham, AL + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Jacksonville, FL + 1 other US site
- Eligibility basics
- Ages 18–55 · Men only
- Recruiting
Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing
Medtronic Cardiac Rhythm and Heart Failure
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
CRISPR Therapeutics AG
- Location
- Boston, MA + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
AstraZeneca
- Location
- Houston, TX
- Eligibility basics
- Ages 18–75
- Recruiting
To Establish the Safety and Effectiveness of the ALPFA GRAIL PFA System for Treating Symptomatic Benign Prostate Hyperplasia (BPH) Also Known as an Enlarged Prostate.
ALPFA Medical
- Location
- Germantown, TN
- Eligibility basics
- Ages 45+ · Men only
- RecruitingPhase 2
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
Daré Bioscience, Inc.
- Location
- Phoenix, AZ + 6 other US sites
- Eligibility basics
- Ages 22–50 · Women only
- RecruitingPhase 3
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
OHB Pediatrics Ltd.
- Location
- San Diego, CA + 4 other US sites
- Eligibility basics
- Ages 1–50
- RecruitingPhase 1
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or…
AbbVie
- Location
- Anniston, AL + 11 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
Jubaan Ltd.
- Location
- Dothan, AL + 7 other US sites
- Eligibility basics
- Ages 45–84
- RecruitingPhase 2
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Bayer
- Location
- Detroit, MI
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
AbbVie
- Location
- Dothan, AL + 60 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
AbbVie
- Location
- Pelham, AL + 58 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
Sling Therapeutics, Inc.
- Location
- Glendale, AZ + 16 other US sites
- Eligibility basics
- Ages 18+
Data source: deploy-time snapshot of the ClinicalTrials.gov API. How we list studies